Related Experiment Video
Updated: Mar 16, 2026

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
Clinical outcomes associated with albuminuria in central Australia: a cohort study
Rebecca Ritte1, Joanne Luke2, Craig Nelson3,4
1Onemda Group, Indigenous Health Equity Unit, Centre for Health Equity, Melbourne School of Population and Global Health, The University of Melbourne, VIC, Melbourne, 3010, Australia. rebecca.ritte@unimelb.edu.au.
Insights
Elevated albumin-to-creatinine ratio (ACR) significantly increases the risk of end-stage kidney disease (ESKD) and dialysis in Aboriginal Australians. Early screening with ACR and the KHA Risk Matrix can identify high-risk individuals in remote communities.
Area of Science:
- Nephrology
- Public Health
- Epidemiology
Background:
- Chronic kidney disease (CKD) and end-stage kidney disease (ESKD) disproportionately affect Aboriginal communities in central Australia.
- Under-diagnosis of CKD and ESKD poses a significant health burden in these populations.
Purpose of the Study:
- To investigate the association between elevated albumin-to-creatinine ratio (ACR) and adverse clinical outcomes in Aboriginal people in central Australia.
- To identify predictors of CKD progression within this demographic.
Main Methods:
- A 10-year cohort study analyzed data from 623 Aboriginal individuals across three central Australian communities.
- Cox proportional hazards models assessed risks of ESKD, dialysis, cardiovascular disease (CVD), and mortality.
- The Kidney Health Australia (KHA) Risk Matrix was used to examine predictors of albuminuria progression.
Main Results:
- A baseline ACR level of ≥3.5 mg/mmol was linked to a nearly 10-fold increased risk of ESKD and a 15-fold increased risk of requiring dialysis.
- Albuminuria ≥3.5 mg/mmol showed a borderline association with a 63% increased risk of CVD.
- Diabetes and a waist-to-hip ratio ≥0.90 independently predicted a two-fold higher risk of progressing to higher ACR levels.
Conclusions:
- A single measurement of moderately increased albuminuria strongly predicts renal failure in Aboriginal Australians.
- Spot urine ACR testing combined with the KHA Risk Matrix offers an efficient screening strategy for CKD and dialysis risk in remote settings.
- Targeting individuals with diabetes and central obesity for interventions may prevent CKD and CVD complications.
Background:
Chronic kidney disease (CKD) and end-stage-kidney disease (ESKD) continue to be under-diagnosed and a major burden for Aboriginal communities in central Australia. The aim of this study was to examine the risk of poor clinical outcomes associated with elevated albumin-to-creatinine ratio (ACR) among Aboriginal people in central Australia.
Methods:
Cox proportional hazards models were used to estimate the risk of end stage kidney disease (ESKD), dialysis, CVD (cardiovascular disease) and mortality associated with participants' baseline albuminuria reading from a 10-year cohort study of Aboriginal people (n = 623) from three communities in central Australia. Predictors of progression of albuminuria were also examined in the context of the Kidney Health Australia (KHA) Risk Matrix.
Results:
A baseline ACR level of ≥3.5 mg/mmol was associated with an almost 10-fold increased risk of ESKD (95%CI 2.07-43.8) and a 15-fold risk of dialysis (95%CI 1.89-121). Albuminuria ≥3.5 mg/mmol was also associated with a borderline 63 % increased risk of CVD (95%CI 0.98-2.71). No significant association was observed with mortality from all-causes or chronic disease. Diabetes and a waist-to-hip ratio ≥0.90 independently predicted a two-fold increased risk of a progression to higher ACR levels.
Conclusions:
A single measure of moderately increased albuminuria was a strong predictor of renal failure in this population. A single spot urine ACR analysis in conjunction with the KHA Risk Matrix may be a useful and efficient strategy to screen for risk of CKD and progression to dialysis in remote communities. A focus on individuals with diabetes and/or central obesity for strategies to avoid increases in albuminuria may also prevent future CKD and CVD complications.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Chronic Kidney Disease II: Clinical Manifestations
Nephrotic Syndrome III : Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care

